Rudolf Bär adds UK head to STADA roles as Roger Scarlett-Smith retires

The retiring Roger Scarlett-Smith is to be replaced as head of UK at Germany’s STADA Arzneimittel (SAZ: Xetra) by Rudolf Bär.

Mr Bär has assumed responsibility for STADA’s UK operations in addition to his current responsibilities as cluster head and vice-president for mid-sized European markets.

He joined STADA in February 2019 in that role after more than 20 years’ experience in the pharmaceutical industry, including in consumer healthcare, specialty and generics. His prior experience includes a period as head of central Eastern Europe, Middle East and Africa at PGT, the joint venture between Procter and Gamble (NYSE: PG) and Teva Pharmaceutical Industries (NYSE: TEVA).